Download PDF
1 / Pages

Other users also viewed these articles

Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19 Francisco Javier Carrasco-Sánchez; Enrique Carretero-Anibarro; Manuel Ángel Gargallo; Ricardo Gómez-Huelgas; Juan Francisco Merino-Torres; Domingo Orozco-Beltrán; Pedro José Pines Corrales; Manuel Antonio Ruiz Quintero;
Endocrinol Diabetes Nutr. 2022;69:209-18
Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial José Antonio Gimeno Orna; Ana Belén Mañas Martínez; Luis Rodríguez Padial; Manuel Anguita Sánchez; Vivencio Barrios; Javier Muñiz García; Antonio Pérez Pérez;
Endocrinol Diabetes Nutr. 2024;71:278-89
Malnutrition risk prevalence in hospitalised patients in Castilla-La Mancha: Ten years after the PREDyCES® study Marta Cano Megías; José Joaquín Alfaro Martínez; Belén Fernández de Bobadilla Pascual; Gessy Bellerive; Álvaro García Manzanares Vázquez de Agredos; Visitación Álvarez de Frutos;
Endocrinol Diabetes Nutr. 2023;70:492-500